Two “new” ADHD meds coming in 2017
Sometimes the more things change, the more they stay the same. Take ADHD meds, for instance. If you are looking for a stimulant you have exactly two choices: amphetamines (like Adderall) or methylphenidate (Ritalin and its ilk).
That doesn’t stop the pharmaceutical companies from offering lots variations on these Schedule II class drugs. The medications are controlled by the FDA. And here it comes again:Shire Pharmaceuticals announced it would begin distribution and marketing of Mydayis later this year.